Zanidatamab (ZW25) is a humanised bispecific monoclonal antibody that simultaneously targets two distinct HER2 epitopes located on ECD2 and ECD4, thereby enhancing receptor clustering and signaling blockade, Zanidatamab exhibits strong anti-tumour activity, supporting its application in HER2-positive cancer research and antibody-based therapeutic development.
Reinheit:
95.00%
CAS Nummer:
[2169946-15-8]
Target-Kategorie:
HER
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten